Aeon Biopharma reduces shareholder quorum requirement to 33.34%

AEON Biopharma, Inc.

Quorum for shareholder meetings changed from a majority to 33.34% of outstanding voting power.
Amendment to Bylaws adopted on December 18, 2024, effective immediately.
Certificate of Amendment filed as Exhibit 3.1 with the SEC.

item 5.03 item 9.01

AEON Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-130805

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.